Showing 1 - 11 results of 11 for search 'Beller, E', query time: 0.04s
Refine Results
-
1
Reporting of effect direction and size in abstracts of systematic reviews. by Beller, E, Glasziou, P, Hopewell, S, Altman, D
Published 2011Journal article -
2
-
3
Focus on sharing individual patient data distracts from other ways of improving trial transparency. by Hoffmann, T, Glasziou, P, Beller, E, Goldacre, B, Chalmers, I
Published 2017Journal article -
4
-
5
Addressing antibiotic resistance - focusing on acute respiratory infections in primary care. by Del Mar, C, Glasziou, P, Lowe, J, van Driel, M, Hoffmann, T, Beller, E
Published 2012Journal article -
6
PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. by Beller, E, Glasziou, P, Altman, D, Hopewell, S, Bastian, H, Chalmers, I, Gøtzsche, P, Lasserson, T, Tovey, D
Published 2013Journal article -
7
Adverse events in patients taking cephalosporins versus placebo for any indication (protocol) by McCullough, A, Scott, A, Macindoe, C, Clark, J, Hansen, M, Beller, E, Aronson, J, Mar, D
Published 2016Journal article -
8
Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. by Glasziou, P, Clarke, P, Alexander, J, Rajmokan, M, Beller, E, Woodward, M, Chalmers, J, Poulter, N, Patel, A
Published 2010Journal article -
9
Adverse events in people taking macrolide antibiotics versus placebo for any indication by Hansen, M, Scott, A, McCullough, A, Thorning, S, Aronson, J, Beller, E, Glasziou, P, Hoffmann, T, Clark, J, Mar, D
Published 2019Journal article -
10
Why Cochrane should prioritise sharing data by Shokraneh, F, Adams, C, Clarke, M, Amato, L, Bastian, H, Beller, E, Brassey, J, Buchbinder, R, Davoli, M, Del Mar, C, Glasziou, P, Gluud, C, Heneghan, C, Hoffmann, T, Ioannidis, J, Jayaram, M, Kwong, J, Moher, D, Ota, E, Sheriff, R, Vale, L, Goldacre, B
Published 2018Journal article -
11
Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial by Glasziou, P, Alexander, J, Beller, E, Clarke, P, Chalmers, J, MacMahon, S, Cooper, M, Ferrannini, E, Glasziou, P, Grobbee, D, Hamet, P, Harrap, S, Heller, S, Lisheng, L, Mancia, G, Marre, M, Mogensen, C, Neal, B, Yu Pan, C, Patel, A, Poulter, N, Rodgers, A, William, B, Woodward, M, Collins, R
Published 2007Journal article